Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02096653 · ClinicalTrials.gov registry record · NA
Fluoroscopically-guided Versus Landmark-guided Sacroiliac Joint Injections
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT02096653: Completed NA study, sponsored by Johns Hopkins University.
NCT02096653 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02096653, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
In this study, the investigators are attempting to determine whether intra- or extra-articular injections are more effective; the relative prevalence rate of intra-articular and extra-articular SI joint pain; and the accuracy of extra-articular injections using fluoroscopy as the reference standard. 124 consecutive patients with mechanical low back pain below L5, tenderness overlying the SI joint(s) and at least 3 positive provocative maneuvers will be randomized to receive SI joint injections by 2 different approaches. Group 1 will receive fluoroscopically-guided injections into the joint. Group 2 will receive landmark-guided injections into the tender area around the joint. In order to determine whether the injection in group 2 was intra-articular or extra-articular, an x-ray will be done after the injection to ascertain the location of contrast spread. The primary outcome measure will be pain relief at 1-month. Patients who obtain benefit at 1-month will be followed at 3-months, while those who fail to obtain benefit will exit the study to receive alternative care.
Interventions
- PROCEDURE X-ray SI joint steroid injection
- PROCEDURE Landmark-guided SI steroid injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2014-05 |
| Est. Completion | 2017-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02096653
The ClinicalTrials.gov registry entry for NCT02096653 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which X-ray SI joint steroid injection is the first listed.
NCT02096653 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02096653 about?
NCT02096653 is a clinical study titled "Fluoroscopically-guided Versus Landmark-guided Sacroiliac Joint Injections". In this study, the investigators are attempting to determine whether intra- or extra-articular injections are more effective; the relative prevalence rate of intra-articular and extra-articular SI joint pain; and the accuracy of extra-articular injections using fluoroscopy as the reference standard....
What is the current status of trial NCT02096653?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2014-05. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02096653?
The interventions under investigation include: X-ray SI joint steroid injection (PROCEDURE), Landmark-guided SI steroid injection (PROCEDURE).
Who is sponsoring clinical trial NCT02096653?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.